Article
A case of advanced medullary thyroid carcinoma successfully treated with sunitinib.
The oncologist - 1 Nov 2009
Bugalho Maria João, Domingues Rita, Borges Alexandra
Abstract excerpt
CONTEXT: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor arising from "C" cells of the thyroid; it is a RET associated cancer that can be sporadic or familial in origin. Advances in understanding the genetic changes associated with the development of MTC explain the growing interest in the therapeutic potential of tyrosine kinase inhibitors. Sunitinib is an orally administered multikinase inhibitor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
